Pharmocokinetics of Meropenem in Chinese Children Receiving Continuous Venovenous Hemodialysis

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-16008703

Enrollment

Unknown

Registered

2016-06-19

Start date

2016-06-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe sepsis

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

1 Years to 18 Years

Inclusion criteria

Inclusion criteria: children suffering from severe sepsis admitted to pediatric intensive care unit

Exclusion criteria

Exclusion criteria: children with renal dysfunction

Design outcomes

Primary

Measure	Time frame
blood concentration of meropenem;	—

Countries

China

Contacts

Public ContactLu Guoping

Children's Hospital, Fudan University

13788904150@163.com+86 18017590817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026